Differing serologic responses to an Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate (PRP-OMPC) vaccine in Australian Aboriginal and Caucasian infants -: implications for disease epidemiology

被引:19
作者
Guthridge, S
McIntyre, P
Isaacs, D
Hanlon, M
Patel, M
机构
[1] Royal Alexandra Hosp Children, Dept Immunol & Infect Dis, Sydney, NSW 2124, Australia
[2] Terr Hlth Serv, Darwin, NT, Australia
[3] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia
关键词
PRP-OMPC vaccine; Aboriginal; serology;
D O I
10.1016/S0264-410X(99)00549-6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
This study compared Hib antibody responses to a single lot of PRP-OMPC vaccine given at 7, 4 and 12 months to 57 Aboriginal infants in rural areas of the Northern Territory and 56 Caucasian infants in Sydney, Australia. The Aboriginal infants had lower levels of antibody in cord blood (P > 0.05), which were significantly lower (P < 0.02) by 2 months of age. Antibody responses to one or two doses of vaccine, measured at 4 and 12 months of age, were similar but the geometric mean titre following the booster dose in Aboriginal infants was significantly lower (1.98 vs 6.04 mcg/ml, P = 0.002). Low preimmunisation antibody is consistent with the early onset of Hib disease in Aboriginal infants before immunisation. Lower responses to boosting could correlate with persistence of Hib colonisation in indigenous populations. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2584 / 2591
页数:8
相关论文
共 36 条
[1]  
*ADV COMM IMM PRAC, 1992, MMWR-MORBID MORTAL W, V46, P878
[2]   The immunogenicity of Haemophilus influenzae: Meningococcal protein conjugate vaccine in Polynesian and non-Polynesian New Zealand infants [J].
Ameratunga, SN ;
Lennon, DR ;
Entwistle, B ;
Robinson, E ;
Ameratunga, RV .
JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 1997, 33 (02) :138-141
[3]   SAFETY AND IMMUNOGENICITY OF OLIGOSACCHARIDE CONJUGATE HAEMOPHILUS-INFLUENZAE TYPE-B (HBOC) VACCINE IN INFANCY [J].
BLACK, SB ;
SHINEFIELD, HR ;
LAMPERT, D ;
FIREMAN, B ;
HIATT, RA ;
POLEN, M ;
VITTINGHOFF, E .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1991, 10 (02) :92-96
[4]   Vaccine failures after primary immunisation with Haemophilus influenzae type-b conjugate vaccine without booster [J].
Booy, R ;
Heath, PT ;
Slack, MPE ;
Begg, N ;
Moxon, ER .
LANCET, 1997, 349 (9060) :1197-1202
[5]   Measuring the impact of conjugate vaccines on invasive Haemophilus influenzae type b infection in Western Australia [J].
Bower, C ;
Condon, R ;
Payne, J ;
Burton, P ;
Watson, C ;
Wild, B .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH, 1998, 22 (01) :67-72
[6]   COMPARATIVE IMMUNOGENICITY OF 4 HAEMOPHILUS-INFLUENZAE TYPE-B CONJUGATE VACCINES IN ALASKA NATIVE INFANTS [J].
BULKOW, LR ;
WAINWRIGHT, RB ;
LETSON, GW ;
CHANG, SJ ;
WARD, JI .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1993, 12 (06) :484-492
[7]   ANTI-PRP ANTIBODY-LEVELS AFTER A PRIMARY SERIES OF PRP-OMPC AND PERSISTENCE OF ANTIBODY-TITERS FOLLOWING PRIMARY AND BOOSTER DOSES [J].
CALANDRA, GB ;
LUKACS, LJ ;
JONAS, LC ;
SANTOSHAM, M ;
WARD, JI ;
GREENBERG, DP ;
DAUM, RS ;
MATTHEWS, H ;
VELLA, PP ;
RYAN, JL .
VACCINE, 1993, 11 :S58-S62
[8]  
CAMPBELL H, 1990, PEDIATRICS, V86, P102
[9]   RESPONSES OF CHILDREN TO BOOSTER IMMUNIZATION WITH THEIR PRIMARY CONJUGATE HAEMOPHILUS-INFLUENZAE TYPE-B VACCINE OR WITH POLYRIBOSYLRIBITOL PHOSPHATE CONJUGATED WITH DIPHTHERIA TOXOID [J].
DECKER, MD ;
EDWARDS, KM ;
BRADLEY, R ;
PALMER, P .
JOURNAL OF PEDIATRICS, 1993, 122 (03) :410-413
[10]  
DOUGLAS RM, 1986, COMMUNITY HEALTH ST, V10, P189